In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection

Infection and Immunity

Volumn 66, Issue 7, 1998, Pages 3303-3310

  Lim, Jean K ^a   Gunther IV, Nereus W ^a   Zhao, Hui ^a   Johnson, David E ^a   Keay, Susan K ^a   Mobley, Harry L T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; MANNOSE;

ADULT; ARTICLE; CONTROLLED STUDY; CYSTITIS; ESCHERICHIA COLI; FEMALE; GENE AMPLIFICATION; GENE SWITCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; STRAIN DIFFERENCE; URINARY TRACT INFECTION;

ESCHERICHIA COLI;

EID: 0031816316     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.7.3303-3310.1998     Document Type: Article

References (48)

1. Abraham, S. N., J. P. Babu, C. S. Giampapa, D. L. Hasty, W. A. Simpson, and E. H. Beachey. 1985. Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect. Immun. 48:625-628.
2. Aronson, M., O. Medalia, L. Schori, D. Mirelman, N. Sharon, and I. Ofek. 1979. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl α-D-mannopyranoside. J. Infect. Dis. 139:329-332.
3. Bahrani, F. K., D. E. Johnson, D. Robbins, and H. L. T. Mobley. 1991. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect. Immun. 59:3574-3580.
4. Bahrani, F. K., G. Massad, C. V. Lockatell, D. E. Johnson, R. G. Russell, J. W. Warren, and H. L. T. Mobley. 1994. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect. Immun. 62:3363-3371.
5. Buchanan, K., S. Falkow, R. A. Hull, and S. I. Hull. 1985. Frequency among Enterobacteriaceae of the DNA sequences encoding type 1 pili. J. Bacteriol. 162:799-803.
6. Connell, H., W. Agace, P. Klemm, M. Schembri, S. Marild, and C. Svanborg. 1996. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc. Natl. Acad. Sci. USA 93:9827-9832.
7. Donnenberg, M. S., and R. A. Welch. 1996. Virulence determinants of uropathogenic Escherichia coli. p. 135-174. In H. L. T. Mobley and J. W. Warren (ed.), Urinary tract infections: molecular pathogenesis and clinical management. ASM Press, Washington, D.C.
8. Duncan, J. L. 1988. Differential effect of Tamm-Horsfall protein or adherence of Escherichia coli to transitional epithelial cells. J. Infect. Dis. 158: 1379-1382.
9. Eisenstein, B. I. 1981. Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control. Science 214:337-339.
10. Foxman, B., L. Zhang, K. Palin, P. Tallman, and C. F. Marrs. 1995. Bacterial virulence characteristics of Escherichia coli isolates from first-time urinary tract infection. J. Infect. Dis. 171:1514-1521.
11. Gally, D. L., J. A. Bogan, B. I. Eisenstein, and I. C. Blomfield. 1993. Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: effects of temperature and media. J. Bacteriol. 175:6186-6193.
12. Griffith, D. P., D. M. Musher, and C. Itin. 1976. Urease: the primary cause of infection-induced urinary stones. Invest. Urol. 13:346-350.
13. Hagberg, L., R. Hull, S. Hull, S. Falkow, R. Freter, and C. Svanborg Edén. 1983. Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect. Immun. 40:265-272.
14. Hagberg, L., I. Engberg, R. Freter, J. Lam, S. Olling, and C. Svanborg Edén. 1983. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect. Immun. 40:273-283.
15. Hagberg, L., U. Jodal, T. Korhonen, G. Lidin-Janson, U. Lindberg, and C. Svanborg Edén. 1981. Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect. Immun. 31:564-570.
16. Hultgren, S. J., T. N. Porter, A. J. Schaeffer, and J. L. Duncan. 1985. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect. Immun. 50:370-377.
17. Hultgren, S. J., W. R. Schwan, A. J. Schaeffer, and J. L. Duncan. 1986. Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect. Immun. 54:613-620.
18. Iwahi, T., Y. Abe, M. Nakao, A. Imada, and K. Tsuchiya. 1983. Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by Escherichia coli in mice. Infect. Immun. 39:1307-1315.
19. Johnson, J. R. 1991. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4:80-125.
20. Kao, J.-S., D. M. Stucker, J. W. Warren, and H. L. T. Mobley. 1997. Pathgenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains. Infect. Immun. 65:2812-2820.
21. Keith, B. R., L. Maurer, P. A. Spears, and P. E. Orndorff. 1986. Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli. Infect. Immun. 53:693-696.
22. Kisielius, P. V., W. R. Schwan, S. K. Amundsen, J. L. Duncan, and A. J. Schaeffer. 1989. In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infection. Infect. Immun. 57:1656-1662.
23. Klemm, P. 1986. Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J. 5:1389-1393.
24. Langermann, S., S. Palaszynski, M. Barnhart, G. Auguste, J. S. Pinkner, J. Burlein, P. Barren, S. Leath, C. H. Hones, and S. J. Hultgren. 1997. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276:607-611.
25. Marc, D., and M. Dho-Moulin. 1996. Analysis of the fim cluster of an avian O2 strain of Escherichia coli: serogroup-specific sites within fimA and nucleotide sequence of fimI. J. Med. Microbiol. 44:444-452.
26. Marild, S., U. Jodal, I. Orskov, F. Orskov, and C. Svanborg Eden. 1989. Special virulence of the Escherichia coli O1:K1:H7 clone in acute pyelonephritis. J. Pediatr. 115:40-45.
27. McClain, M. S., I. C. Blomfield, and B. I. Eisenstein. 1991. Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli. J. Bacteriol. 173:5308-5314.
28. Mecsas, J., and E. J. Strauss. 1996. Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands. Emerg. Infect. Dis. 2:271-288.
29. Michaels, E. K., J. S. Chmiel, B. J. Plotkin, and A. J. Schaeffer. 1983. Effect of D-mannose and D-glucose on Escherichia coli bacterium in rats. Urol. Res. 11:97-102.
30. Mobley, H. L. T. 1997. Vaccines against Escherichia coli and Proteus urinary tract confections, p. 945-962. In M. M. Levine, G. C. Woodrow, J. B. Kaper, and G. S. Cobon (ed.), New generation vaccines, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
31. Mobley, H. L. T., D. M. Green, A. L. Trifillis, D. E. Johnson, G. R. Chippendale, C. V. Lockatell, B. D. Jones, and J. W. Warren. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58:1281-1289.
32. Mobley, H. L. T., K. G. Jarvis, J. P. Elwood, D. I. Whittle, C. V. Lockatell, R. G. Russell, D. E. Johnson, M. S. Donenberg, and J. W. Warren. 1993. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of αGal(1-4)βGal binding in virulence of a wild-type strain. Mol. Microbiol. 10:143-155.
33. Mobley, H. L. T., and J. W. Warren. 1987. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J. Clin. Microbiol. 25:2216-2217.
34. Nowicki, B., M. Rhen, V. Vaisanen-Rhen, A. Pere, and T. K. Korhonen. 1984. Immunofluorescence study of fimbrial phase variation in Escherichia coli KS71. J. Bacteriol. 160:691-695.
35. Ofek, I., A. Mosek, and N. Sharon. 1981. Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine. Intect. Immun. 34:708-711.
36. O'Hanley, P. 1996. Prospects for urinary tract infection vaccines, p. 405-425. In H. L. T. Mobley and J. W. Warren (ed.), Urinary tract infections: molecular pathogenesis and clinical management. ASM Press, Washington, D.C.
37. Parkkinen, J., R. Virkola, and T. K. Korhonen. 1988. Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins. Infect. Immun. 56:2623-2630.
38. Pere, A., B. Nowicki, H. Saxen, A. Siitonen, and T. K. Korhonen. 1987. Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J. Infect. Dis. 156:567-574.
39. Leu affects type 1 fimbriation in pathogenic Escherichia coli by control of FimB recombinase expression. Mol. Microbiol. 25:871-882.
40. Sareneva, T., H. Holthofer, and T. K. Korhonen. 1990. Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract. Infect. Immun. 58:3330-3336.
41. Schaeffer, A. J. 1991. Potential role of phase variation of type 1 pili in urinary tract infection and bacterial prostatitis. Infection 19(Suppl. 3):144-149.
42. Schaeffer, A. J., W. R. Schwan, S. J. Hultgren, and J. L. Duncan. 1987. Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice. Infect. Immun. 55:373-380.
43. Schoolnik, G. K. 1989. How Escherichia coli infects the urinary tract. N. Engl. J. Med. 320:804-805.
44. Siitonen, A. 1994. What makes Escherichia coli pathogenic? Ann. Med. 26:229-231.
45. Silverblatt, F. J., and L. S. Cohen. 1979. Antipili antibody affords protection against experimental ascending pyelonephritis. J. Clin. Invest. 64:333-336.
46. Warren, J. W. 1996. Clinical presentations and epidemiology of urinary tract infections. p. 3-27. In H. L. T. Mobley and J. W. Warren (ed.), Urinary tract infections: molecular pathogenesis and clinical management. ASM Press, Washington, D.C.
47. Wold, A. E., M. Thorssén, S. Hull, and C. Svanborg Edén. 1988. Attachment of Escherichia coli via mannose-or Galα1→4 Galβ-containing receptors to human colonic epithelial cells. Infect. Immun. 56:2531-2537.
48. Zhao, H., X. Li, D. E. Johnson, I. Blomfield, and H. L. T. Mobley. 1997. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Mol. Microbiol. 23:1009-1019.